|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00151866 |
|
Date of registration:
|
07/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
|
|
Scientific title:
|
A Multicentre Randomised Study of the Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma |
|
Date of first enrolment:
|
October 2003 |
|
Target sample size:
|
180 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00151866 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
J.L.H. Kerkhoffs, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Sanquin rbbd |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:patients > 18 years expected to receive platelet transfusions and
informed consent -
Exclusion Criteria:HLA- and/or HPA- alloimmunization
-
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hemato-Oncologic Patients
|
|
Myelosuppression
|
|
Thrombocytopenia
|
|
Intervention(s)
|
|
Procedure: platelet transfusion
|
|
Primary Outcome(s)
|
|
Corrected count increment
|
|
Secondary Outcome(s)
|
|
Bleeding complications
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|